• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数与结肠癌筛查:系统评价和荟萃分析。

Body mass index and colon cancer screening: a systematic review and meta-analysis.

机构信息

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):737-46. doi: 10.1158/1055-9965.EPI-11-0826. Epub 2012 Apr 4.

DOI:10.1158/1055-9965.EPI-11-0826
PMID:22492832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3930882/
Abstract

BACKGROUND

Obesity is associated with increased colon cancer mortality and lower rates of mammography and Pap testing.

METHODS

We conducted a systematic review to determine whether obesity is associated with lower rates of colon cancer screening. We searched the PubMed, CINAHL, and Cochrane Library databases. Two investigators reviewed citations, abstracts, and articles independently. Two investigators abstracted study information sequentially and evaluated quality independently using standardized forms. We included all studies in our qualitative syntheses. We used random effects meta-analyses to combine those studies providing screening results by the following body mass index (BMI) categories: Normal, 18.5-24.9 kg/m(2) (reference); overweight, 25-29.9 kg/m(2); class I obesity, 30-34.9 kg/m(2); class II obesity, 35-39.9 kg/m(2); and class III obesity, ≥ 40 kg/m(2).

RESULTS

Of 5,543 citations, we included 23 articles. Almost all studies were cross-sectional and ascertained BMI and screening through self-report. BMI was not associated with colon cancer screening overall. The subgroup of obese white women reported lower rates of colon cancer screening compared with those with a normal BMI with combined ORs (95% CI) of 0.87 (0.82-0.93), 0.80 (0.65-0.99), and 0.73 (0.58-0.94) for class I, II, and III obesity, respectively. Results were similar among white men with class II obesity.

CONCLUSIONS

Overall, BMI was not associated with colon cancer screening. Obese white men and women may be less likely to undergo colon cancer screening compared with those with a normal BMI.

IMPACT

Further investigation of this disparity may reduce the risk of obesity-related colon cancer death.

摘要

背景

肥胖与结肠癌死亡率增加以及乳房 X 线摄影和巴氏试验检查率降低有关。

方法

我们进行了一项系统评价,以确定肥胖是否与较低的结肠癌筛查率有关。我们检索了 PubMed、CINAHL 和 Cochrane 图书馆数据库。两名调查员独立审查了引文、摘要和文章。两名调查员顺序提取研究信息,并使用标准化表格独立评估质量。我们将所有符合条件的研究纳入定性综合分析。我们使用随机效应荟萃分析来合并提供以下体重指数(BMI)分类筛查结果的研究:正常体重,18.5-24.9 kg/m2(参考);超重,25-29.9 kg/m2;I 级肥胖,30-34.9 kg/m2;II 级肥胖,35-39.9 kg/m2;III 级肥胖,≥40 kg/m2。

结果

在 5543 条引文中,我们纳入了 23 篇文章。几乎所有的研究都是横断面的,通过自我报告来确定 BMI 和筛查情况。总体而言,BMI 与结肠癌筛查无关。肥胖的白人女性亚组报告的结肠癌筛查率低于 BMI 正常的女性,合并 OR(95%CI)分别为 0.87(0.82-0.93)、0.80(0.65-0.99)和 0.73(0.58-0.94),用于 I 级、II 级和 III 级肥胖。在白人男性中,II 级肥胖也有类似的结果。

结论

总体而言,BMI 与结肠癌筛查无关。肥胖的白人男性和女性进行结肠癌筛查的可能性可能低于 BMI 正常的人群。

影响

进一步研究这种差异可能会降低肥胖相关结肠癌死亡的风险。

相似文献

1
Body mass index and colon cancer screening: a systematic review and meta-analysis.体重指数与结肠癌筛查:系统评价和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):737-46. doi: 10.1158/1055-9965.EPI-11-0826. Epub 2012 Apr 4.
2
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
3
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
4
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
5
Obesity and mammography: a systematic review and meta-analysis.肥胖与乳房 X 光检查:系统评价与荟萃分析。
J Gen Intern Med. 2009 May;24(5):665-77. doi: 10.1007/s11606-009-0939-3. Epub 2009 Mar 11.
6
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
7
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.改变卫生专业人员行为及护理组织方式的干预措施,以促进超重或肥胖儿童及成人减轻体重。
Cochrane Database Syst Rev. 2017 Nov 30;11(11):CD000984. doi: 10.1002/14651858.CD000984.pub3.
8
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.在初级保健中使用药物治疗肥胖患者的临床效果和成本效益如何?系统评价。
Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050.
9
Obesity as an independent risk factor for COVID-19 severity and mortality.肥胖是 COVID-19 严重程度和死亡率的独立危险因素。
Cochrane Database Syst Rev. 2023 May 24;5(5):CD015201. doi: 10.1002/14651858.CD015201.
10
Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.针对12至17岁超重或肥胖青少年的饮食、体育活动及行为干预措施。
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012691. doi: 10.1002/14651858.CD012691.

引用本文的文献

1
Patient perceived weight stigma and patient-centered language use preferences: A cross-sectional mixed methods analysis conducted in a large academic medical center.患者感知到的体重歧视及以患者为中心的语言使用偏好:在一家大型学术医疗中心进行的横断面混合方法分析。
PLoS One. 2025 Feb 10;20(2):e0314269. doi: 10.1371/journal.pone.0314269. eCollection 2025.
2
Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample.全国样本中癌症幸存者的生存护理计划和对乳腺癌及宫颈癌筛查指南的遵循情况。
Support Care Cancer. 2024 Nov 18;32(12):798. doi: 10.1007/s00520-024-08986-2.
3
Opportunities for General Internal Medicine to Promote Equity in Obesity Care.普通内科促进肥胖症护理公平性的机遇。
J Gen Intern Med. 2024 Oct 16. doi: 10.1007/s11606-024-09084-z.
4
Obesity and cancer stem cells: Roles in cancer initiation, progression and therapy resistance.肥胖与癌症干细胞:在癌症起始、进展及治疗抗性中的作用
World J Stem Cells. 2023 Apr 26;15(4):120-135. doi: 10.4252/wjsc.v15.i4.120.
5
FABP4 in obesity-associated carcinogenesis: Novel insights into mechanisms and therapeutic implications.脂肪酸结合蛋白4在肥胖相关致癌作用中的研究:对机制及治疗意义的新见解
Front Mol Biosci. 2022 Aug 19;9:973955. doi: 10.3389/fmolb.2022.973955. eCollection 2022.
6
Efficacy and tolerability of colonoscopies in overweight and obese patients: Results from a national database on gastrointestinal endoscopic outcomes.超重和肥胖患者结肠镜检查的有效性和耐受性:来自全国胃肠内镜检查结果数据库的结果。
Endosc Int Open. 2022 Apr 14;10(4):E311-E320. doi: 10.1055/a-1672-3525. eCollection 2022 Apr.
7
Lower Utilization of Colorectal Cancer Screening Among Vegetarians, Adventist Health Study-2.素食者结直肠癌筛查利用率较低,这是基于 Adventist Health Study-2 的研究结果。
J Cancer Educ. 2022 Dec;37(6):1948-1956. doi: 10.1007/s13187-021-02065-4. Epub 2021 Jul 9.
8
FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport.脂肪酸结合蛋白4通过调节脂肪酸转运促进结肠癌的侵袭和转移。
Cancer Cell Int. 2020 Oct 19;20:512. doi: 10.1186/s12935-020-01582-4. eCollection 2020.
9
Colorectal cancer risk based on extended family history and body mass index.基于家族史和体重指数的结直肠癌风险
Genet Epidemiol. 2020 Oct;44(7):778-784. doi: 10.1002/gepi.22338. Epub 2020 Jul 16.
10
A Comparative Study Evaluating the Incidence of Colorectal Neoplasia(s) in Candidates for Bariatric Surgery by Screening Colonoscopy, 40-49 Versus 50-65 Years Old: a Preliminary Study.一项比较研究:通过结肠镜筛查评估40 - 49岁与50 - 65岁肥胖症手术候选者结直肠肿瘤的发病率:一项初步研究。
Obes Surg. 2019 Aug;29(8):2430-2435. doi: 10.1007/s11695-019-03819-2.

本文引用的文献

1
Colorectal cancer screening among primary care patients: does risk affect screening behavior?基层医疗患者中的结直肠癌筛查:风险是否会影响筛查行为?
J Community Health. 2011 Aug;36(4):605-11. doi: 10.1007/s10900-010-9348-0.
2
Protection from colorectal cancer after colonoscopy: a population-based, case-control study.结肠镜检查后的结直肠癌预防:一项基于人群的病例对照研究。
Ann Intern Med. 2011 Jan 4;154(1):22-30. doi: 10.7326/0003-4819-154-1-201101040-00004.
3
Relationship between family history of breast cancer and health-related behavior.乳腺癌家族史与健康相关行为的关系。
Behav Med. 2010 Oct-Dec;36(4):123-9. doi: 10.1080/08964289.2010.516783.
4
Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey.美国癌症筛查的数据和趋势:来自 2005 年全国健康访谈调查的结果。
Cancer. 2010 Oct 15;116(20):4872-81. doi: 10.1002/cncr.25215.
5
Quality of care among obese patients.肥胖患者的护理质量。
JAMA. 2010 Apr 7;303(13):1274-81. doi: 10.1001/jama.2010.339.
6
Obesity and receipt of clinical preventive services in veterans.肥胖与退伍军人获得临床预防服务。
Obesity (Silver Spring). 2010 Sep;18(9):1827-35. doi: 10.1038/oby.2010.40. Epub 2010 Mar 4.
7
Endoscopy in the obese patient.肥胖患者的内镜检查。
Gastroenterol Clin North Am. 2010 Mar;39(1):87-97. doi: 10.1016/j.gtc.2009.12.009.
8
Prevalence and trends in obesity among US adults, 1999-2008.美国成年人肥胖率的流行趋势及变化,1999-2008 年。
JAMA. 2010 Jan 20;303(3):235-41. doi: 10.1001/jama.2009.2014. Epub 2010 Jan 13.
9
Race moderates the relationship between obesity and colorectal cancer screening in women.种族因素会调节肥胖与女性结直肠癌筛查之间的关系。
Cancer Causes Control. 2010 Mar;21(3):373-85. doi: 10.1007/s10552-009-9469-x. Epub 2009 Nov 26.
10
Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001-2006.基于自我报告的体重和身高的 BMI 测量的准确性和有用性:来自 NHANES & NHIS 2001-2006 的发现。
BMC Public Health. 2009 Nov 19;9:421. doi: 10.1186/1471-2458-9-421.